Study participants also included Dr. Nishanth Belugali Nataraj, Dr. Moshit Lindzen, Dr. Soma Ghosh, Dr. Arturo Simoni-Nieves, Aakanksha Verma, Rishita Chatterjee, Arunachalam Sekar, Dr. Suvendu Giri and Diana Drago-Garcia of Weizmann’s Immunology and Regenerative Biology Department; Dr. Welles Robinson, Dr. Sanju Sinha and Prof. Eytan Ruppin of the National Cancer Institute, Bethesda, Maryland; Drs. Benny Zhitomirsky, Yaara Oren, Brian P. Danysh, Jideofor Ezike and Prof. Gad Getz of the Broad Institute of MIT and Harvard; Dr. Sara Oster and Prof. Rami I. Aqeilan of the Hebrew University of Jerusalem; Dr. Saptaparna Mukherjee and Prof. Moshe Oren of Weizmann’s Molecular Cell Biology Department; Drs. Rainer Will and Simone Borgoni and Prof. Stefan Wiemann of the German Cancer Research Center (DKFZ); Dr. Alexander Brandis of Weizmann’s Life Sciences Core Facilities Department; D. Lucas Kerr and Drs. Wei Wu, Collin M. Blakely and Trever G. Bivona of the University of California, San Francisco; Dr. Youngmin Chung and Dr. Joo Sang Lee of Sungkyunkwan University, Suwon, Republic of Korea; Profs. Mattia Lauriola, Michelangelo Fiorentino and Andrea Ardizzoni of the University of Bologna, Italy; Dr. Laxmi Parida of IBM Research, Yorktown Heights, New York; Prof. Joan S. Brugge of the Harvard Medical School; and Prof. Aviv Regev of Genentech Inc., South San Francisco, California.